‘World first’ computer-designed vaccine shows immune response in early human testing
Cambridge-led research shows an AI-designed vaccine platform producing broad immune protection across virus families, with early Phase 1 human trials confirming safety and immune response, pointing toward reduced need for frequent strain-specific vaccine updates.